title: Guidelines for the use of palivizumab in infants and young children with congenital heart disease.
authors.affiliation: Guideline Preparation and Review Committee, Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Japan.
authors.forename: Makoto
authors.initials: M
authors.lastname: Nakazawa
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Saji
authors.forename: Fukiko
authors.initials: F
authors.lastname: Ichida
authors.forename: Kotaro
authors.initials: K
authors.lastname: Oyama
authors.forename: Kensuke
authors.initials: K
authors.lastname: Harada
authors.forename: Satoshi
authors.initials: S
authors.lastname: Kusuda
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002675:Child, Preschool; D015897:Comorbidity; D004347:Drug Interactions; D006330:Heart Defects, Congenital / Q000453:epidemiology*; D006801:Humans; D007223:Infant; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy* / Q000453:epidemiology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab